Cite the Following Article
Synthesis and evaluation of cell-permeable biotinylated PU-H71 derivatives as tumor Hsp90 probes
Tony Taldone, Anna Rodina, Erica M. DaGama Gomes, Matthew Riolo, Hardik J. Patel, Raul Alonso-Sabadell, Danuta Zatorska, Maulik R. Patel, Sarah Kishinevsky and Gabriela Chiosis
Beilstein J. Org. Chem. 2013, 9, 544–556.
https://doi.org/10.3762/bjoc.9.60
How to Cite
Taldone, T.; Rodina, A.; DaGama Gomes, E. M.; Riolo, M.; Patel, H. J.; Alonso-Sabadell, R.; Zatorska, D.; Patel, M. R.; Kishinevsky, S.; Chiosis, G. Beilstein J. Org. Chem. 2013, 9, 544–556. doi:10.3762/bjoc.9.60
Download Citation
Citation data can be downloaded as file using the "Download" button or used for copy/paste from the text window
below.
Citation data in RIS format can be imported by all major citation management software, including EndNote,
ProCite, RefWorks, and Zotero.
Citations to This Article
Up to 20 of the most recent references are displayed here.
Scholarly Works
- Bailey, B. L.; Nguyen, W.; Cowman, A. F.; Sleebs, B. E. Chemo-proteomics in antimalarial target identification and engagement. Medicinal research reviews 2023, 43, 2303–2351. doi:10.1002/med.21975
- Zhu, S.; Lu, Y.; Jin, J.; Yu, J.; Lu, W. An HSP90 inhibitor based fluorescent probe for selective tumor targeting. Dyes and Pigments 2021, 196, 109783. doi:10.1016/j.dyepig.2021.109783
- Mathien, S.; Tesnière, C.; Meloche, S. Regulation of Mitogen-Activated Protein Kinase Signaling Pathways by the Ubiquitin-Proteasome System and Its Pharmacological Potential. Pharmacological reviews 2021, 73, 263–296. doi:10.1124/pharmrev.120.000170
- Yan, P.; Wang, T.; Guzman, M. L.; Peter, R. I.; Chiosis, G. Chaperome Networks - Redundancy and Implications for Cancer Treatment. Advances in experimental medicine and biology 2020, 1243, 87–99. doi:10.1007/978-3-030-40204-4_6
- Taldone, T.; Wang, T.; Rodina, A.; Pillarsetty, N. V. K.; Digwal, C. S.; Sharma, S.; Yan, P.; Joshi, S.; Pagare, P. P.; Bolaender, A.; Roboz, G. J.; Guzman, M. L.; Chiosis, G. A Chemical Biology Approach to the Chaperome in Cancer—HSP90 and Beyond. Cold Spring Harbor perspectives in biology 2020, 12, a034116. doi:10.1101/cshperspect.a034116
- Wang, T.; Rodina, A.; Dunphy, M.; Corben, A. D.; Modi, S.; Guzman, M. L.; Gewirth, D. T.; Chiosis, G. Chaperome heterogeneity and its implications for cancer study and treatment. The Journal of biological chemistry 2018, 294, 2162–2179. doi:10.1074/jbc.rev118.002811
- Tomohiro, T. Tag-Creation Approaches for Highly Efficient Profiling of Interacting Proteins and Domains. Photoaffinity Labeling for Structural Probing Within Protein; Springer Japan, 2017; pp 13–43. doi:10.1007/978-4-431-56569-7_2
- Iwamoto, K.; Uehara, Y.; Inoue, Y.; Taguchi, K.; Muraoka, D.; Ogo, N.; Matsuno, K.; Asai, A. Inhibition of STAT3 by Anticancer Drug Bendamustine. PloS one 2017, 12, e0170709. doi:10.1371/journal.pone.0170709
- Shrestha, L.; Patel, H. J.; Chiosis, G. Chemical Tools to Investigate Mechanisms Associated with HSP90 and HSP70 in Disease. Cell chemical biology 2016, 23, 158–172. doi:10.1016/j.chembiol.2015.12.006
- Proia, D. A.; Smith, D. L.; Zhang, J.; Jimenez, J.-P.; Sang, J.; Ogawa, L. S.; Sequeira, M.; Acquaviva, J.; He, S.; Zhang, C.; Khazak, V.; Astsaturov, I.; Inoue, T.; Tatsuta, N.; Osman, S.; Bates, R. C.; Chimmanamada, D.; Ying, W. HSP90 Inhibitor-SN-38 Conjugate Strategy for Targeted Delivery of Topoisomerase I Inhibitor to Tumors. Molecular cancer therapeutics 2015, 14, 2422–2432. doi:10.1158/1535-7163.mct-15-0455
- Krasnov, V. P.; Gruzdev, D. A.; Chulakov, E. N.; Vigorov, A. Y.; Musiyak, V. V.; Matveeva, T. V.; Tumashov, A. A.; Levit, G. L.; Charushin, V. N. Synthesis of novel purin-6-yl conjugates with heterocyclic amines linked via 6-aminohexanoyl fragment. Mendeleev Communications 2015, 25, 412–414. doi:10.1016/j.mencom.2015.11.003
- Yuzefovych, Y.; Blasczyk, R.; Huyton, T. Oncogenic acidic nuclear phosphoproteins ANP32C/D are novel clients of heat shock protein 90. Biochimica et biophysica acta 2015, 1853, 2338–2348. doi:10.1016/j.bbamcr.2015.06.007
